IE49591B1 - Pyrimidine derivatives - Google Patents

Pyrimidine derivatives

Info

Publication number
IE49591B1
IE49591B1 IE864/80A IE86480A IE49591B1 IE 49591 B1 IE49591 B1 IE 49591B1 IE 864/80 A IE864/80 A IE 864/80A IE 86480 A IE86480 A IE 86480A IE 49591 B1 IE49591 B1 IE 49591B1
Authority
IE
Ireland
Prior art keywords
pyrimidine
isopropylamino
general formula
aralkyloxy
alkoxy
Prior art date
Application number
IE864/80A
Other languages
English (en)
Other versions
IE800864L (en
Original Assignee
Soc D Etudes Prod Chimique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Soc D Etudes Prod Chimique filed Critical Soc D Etudes Prod Chimique
Publication of IE800864L publication Critical patent/IE800864L/xx
Publication of IE49591B1 publication Critical patent/IE49591B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
IE864/80A 1979-04-30 1980-04-28 Pyrimidine derivatives IE49591B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7914987 1979-04-30

Publications (2)

Publication Number Publication Date
IE800864L IE800864L (en) 1980-10-30
IE49591B1 true IE49591B1 (en) 1985-10-30

Family

ID=10504858

Family Applications (2)

Application Number Title Priority Date Filing Date
IE864/80A IE49591B1 (en) 1979-04-30 1980-04-28 Pyrimidine derivatives
IE865/80A IE49709B1 (en) 1979-04-30 1980-04-28 Pyrimidine derivatives

Family Applications After (1)

Application Number Title Priority Date Filing Date
IE865/80A IE49709B1 (en) 1979-04-30 1980-04-28 Pyrimidine derivatives

Country Status (26)

Country Link
JP (2) JPS55145670A (enExample)
AR (2) AR222870A1 (enExample)
AT (2) AT380013B (enExample)
BE (2) BE882593A (enExample)
CH (2) CH645361A5 (enExample)
DK (2) DK183780A (enExample)
EG (2) EG14284A (enExample)
ES (2) ES490999A0 (enExample)
FI (2) FI66358C (enExample)
FR (2) FR2455588A1 (enExample)
GB (2) GB2054556B (enExample)
HK (2) HK55583A (enExample)
IE (2) IE49591B1 (enExample)
IN (2) IN154066B (enExample)
IT (2) IT1141296B (enExample)
LU (2) LU82333A1 (enExample)
MA (1) MA18824A1 (enExample)
MX (2) MX6514E (enExample)
MY (2) MY8400204A (enExample)
NL (2) NL8002271A (enExample)
NO (2) NO154056C (enExample)
NZ (2) NZ193421A (enExample)
OA (2) OA06527A (enExample)
PT (2) PT71154A (enExample)
SG (2) SG22283G (enExample)
ZA (2) ZA801958B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63145595U (enExample) * 1987-03-13 1988-09-26
JPS645795U (enExample) * 1987-06-26 1989-01-13
JPH01100695U (enExample) * 1987-12-21 1989-07-06
US5264435A (en) * 1988-12-29 1993-11-23 Mitsui Petrochemical Industries, Ltd. Pyrimidines and their pharmaceutical acceptable salts, and their use as medicines
HU206337B (en) * 1988-12-29 1992-10-28 Mitsui Petrochemical Ind Process for producing pyrimidine derivatives and pharmaceutical compositions
USD500447S1 (en) * 2003-08-07 2005-01-04 Kranson Industries Oval bottle
USD505864S1 (en) * 2003-08-07 2005-06-07 Kranson Industries Oval bottle

Also Published As

Publication number Publication date
PT71155A (en) 1980-05-01
MY8400204A (en) 1984-12-31
NO154056B (no) 1986-04-01
GB2055801A (en) 1981-03-11
HK55683A (en) 1983-11-25
ATA221580A (de) 1985-08-15
BE882593A (fr) 1980-07-31
FI66359C (fi) 1984-10-10
EG14284A (en) 1983-09-30
FI801084A7 (fi) 1980-10-31
NO154056C (no) 1986-07-09
FR2455589B1 (enExample) 1981-07-10
ES491000A0 (es) 1981-02-16
MY8400203A (en) 1984-12-31
PT71154A (en) 1980-05-01
NZ193421A (en) 1981-11-19
HK55583A (en) 1983-11-25
JPS55145670A (en) 1980-11-13
DK183880A (da) 1980-10-31
BE882594A (fr) 1980-07-31
ZA801960B (en) 1981-04-29
CH645633A5 (en) 1984-10-15
GB2055801B (en) 1983-02-09
IE49709B1 (en) 1985-11-27
NO801235L (no) 1980-10-31
FR2455588B1 (enExample) 1983-04-15
OA06525A (fr) 1981-07-31
CH645361A5 (en) 1984-09-28
ATA221680A (de) 1985-08-15
IN154066B (enExample) 1984-09-15
MX5878E (es) 1984-08-16
IT1141296B (it) 1986-10-01
GB2054556A (en) 1981-02-18
AT380013B (de) 1986-03-25
LU82333A1 (fr) 1980-07-02
IT8021543A0 (it) 1980-04-22
AT380012B (de) 1986-03-25
ZA801958B (en) 1981-04-29
NL8002272A (nl) 1980-11-03
FR2455589A1 (fr) 1980-11-28
FI66359B (fi) 1984-06-29
NL8002271A (nl) 1980-11-03
NO801234L (no) 1980-10-31
NO154055C (no) 1986-07-09
JPS6116272B2 (enExample) 1986-04-28
ES8103060A1 (es) 1981-02-16
FI66358B (fi) 1984-06-29
ES8103061A1 (es) 1981-02-16
FR2455588A1 (fr) 1980-11-28
DK183780A (da) 1980-10-31
SG22283G (en) 1983-12-16
NO154055B (no) 1986-04-01
MX6514E (es) 1985-06-26
MA18824A1 (fr) 1980-12-31
FI801083A7 (fi) 1980-10-31
ES490999A0 (es) 1981-02-16
IT8021542A0 (it) 1980-04-22
IN154067B (enExample) 1984-09-15
IE800864L (en) 1980-10-30
JPS55145671A (en) 1980-11-13
OA06527A (fr) 1981-07-31
IT1141487B (it) 1986-10-01
AR222870A1 (es) 1981-06-30
FI66358C (fi) 1984-10-10
NZ193422A (en) 1981-12-15
LU82332A1 (fr) 1980-07-02
SG22583G (en) 1983-12-16
EG14259A (en) 1983-09-30
IE800865L (en) 1980-10-30
AR222869A1 (es) 1981-06-30
GB2054556B (en) 1983-01-26
JPS6116273B2 (enExample) 1986-04-28

Similar Documents

Publication Publication Date Title
DE3236725C2 (enExample)
CA2103072C (en) Pleuromutilin derivatives
GB2045756A (en) Hydroxy derivatives of 2- isopropylamino-pyrimidine
DE3448320C2 (enExample)
US5137921A (en) Inhibitory agent of an increase in blood sugar level
IE49709B1 (en) Pyrimidine derivatives
US4013699A (en) Aluminium and/or magnesium salts of amino-acids
EP0022515A1 (en) Anthracycline glycosides, process for their preparation and therapeutical composition containing them
CA2007785C (en) 1-[3-(2-hydroxy-3-alkylaminopropoxy)-2-thienyl] -3-phenyl-1-propanones and a process for the preparation thereof
DE69107431T2 (de) Deacetylcolchicinderivate.
US3966779A (en) Thymol derivatives and a process for their preparation
CA1076562A (en) Neamine derivatives and process for preparing the same
US4276294A (en) Benzofurylpiperazines
DE2650366C3 (de) Verwendung eines 5-Fluoruracilde-
US4297509A (en) Process for preparing alkali metal salts 3-amino-2, 5-dichlorobenzoic acid
RU1831471C (ru) Способ получени комплексных соединений псевдопримицина
US4704458A (en) Process for the epimerization of aminated phthalideisoquinolines
AU7761587A (en) Process
US2970159A (en) Hydrazine derivatives
JPH0633263B2 (ja) ７−ヒドロキシグアニン誘導体及びその製造方法並びにそれを有効成分とする抗腫瘍剤
US4731474A (en) Novel therapeutic compounds useful as hypolipidemic and hypocholesteremic agents
GB2023574A (en) N-cyano-azomethine derivatives
EP0110116B1 (de) Verfahren zur Herstellung von Keten-O,N-acetalen
WO1988010252A1 (en) Prostaglandin derivates, their process and pharmaceutical compositions
Plate et al. A biomimetic approach to sporidesmins. synthesis of an α, β-epoxytryptophan derivative